Inspection Findings:
2. Resident 1 was admitted to the facility in 02/2020 with diagnoses including hypertension.Review of the resident's 12/02/22 physician orders, the facility's bowel tracking log, and the 12/02/22 through 01/08/23 MARs revealed the following:* Cavilon barrier cream (for skin breakdown) and fluticasone nasal spray were ordered to be administered daily, but listed as PRN on the MAR. The medications were not administered to the resident during the time frame reviewed.* There was no documented evidence of a physician order in the resident's facility record for PRN Milk of Magnesia (for constipation), which was administered on 12/24/22 and 01/04/23.* Physician orders for PRN bowel medications for constipation indicated staff were to administer Miralax on day two without a bowel movement, Senna on day three without a bowel movement, and a bisacodyl suppository on day four.Documentation on the MAR indicated the medications were not administered to the resident in the time frame ordered by the physician on multiple occasions.The MAR and physician orders were reviewed with Staff 1 and Staff 2. They acknowledged the discrepancies documented above. The need to ensure there were signed physician orders in the resident's facility record for all medications the facility was responsible to administer and orders were carried out as prescribed was discussed with and acknowledged by Staff 1 (Executive Director) and Staff 2 (Wellness Director/LPN) on 01/11/23.
3. Resident 4 was admitted to the facility in 12/2021 with diagnoses of heart disease, osteoporosis, and lumbar fracture. Review of Resident 4's MAR, dated 12/01/22 through 01/09/23, and physician orders, dated 12/05/22, identified the following deficiencies:The following scheduled medications had missed doses on the dates shown, with the reason listed as "awaiting delivery":* Senna-Time 8.6 mg (for constipation): 12/06/22, 12/07/22, 01/06/23, 01/07/23, 01/08/23;* Carvedilol 3.125 mg (for heart health): 12/07/22, 12/08/22, 12/09/22, 12/10/22, 01/08/23;* Oyster Shell Calcium 500 mg (supplement): 12/07/22, 12/08/22, 12/09/22, 12/10/22, 01/08/23;* Acetaminophen 325 mg (for arthritis): 12/10/22;* Modafinil 100 mg (for sleep apnea): 12/12/22;* Clopidogrel 75 mg (for chest pain): 12/14/22, 12/15/22; and* Atorvastatin 10 mg (for high cholesterol): 01/08/23.While the facility was awaiting delivery of these medications, the resident was not receiving them, which constituted failure to follow physician orders.On 01/12/23 the need to ensure all written orders were carried out as prescribed was discussed with Staff 1 (Executive Director), Staff 2 (Wellness Director/LPN) and Staff 3 (RN). They acknowledged the findings, and Staff 2 stated the facility was working to improve the medication systems.
Based on interview and record review, it was determined the facility failed to ensure physician orders were carried out as prescribed and all medication and treatment orders were documented in the resident's facility record for medications and treatments the facility was responsible for administering for 3 of 4 sampled residents (#s 1, 4, and 5) whose MARs were reviewed. Findings include, but are not limited to:1. Resident 5 was admitted to the facility in 10/2019 with diagnoses including diabetes.Review of the resident's 12/01/22 through 01/09/23 MARs and physician orders revealed the following deficiencies:a. The resident missed doses of the following scheduled medication on the dates listed, with the reason given as "awaiting delivery":* Amlodipine Besylate 10 mg (for hypertension): 12/05/22, 12/06/22;* Atorvastatin 40 mg (for cholesterol): 12/10/22, 12/11/22, 12/12/22, 12/13/22, 12/14/22, 12/15/22, 12/17/22;* Glipizide 5 mg (for diabetes): 01/04/23, 01/05/23, 01/06/23, 01/07/23; and* Lisinopril 10 mg (for hypertension): 12/05/22, 12/06/22.While the facility was awaiting delivery of these medications, the resident was not receiving them, which constituted failure to follow physician orders.b. The resident had the following orders for Lisinopril (for blood pressure):* 12/06/22 5 mg once a day;* 12/08/22 10 mg once a day; and* 12/13/22 10 mg once a day.From 12/08/22 through 01/09/23 the resident was administered 5 mg per day of Lisinopril.In an interview with Staff 2 (Wellness Director/LPN) on 01/10/23, she verified there were discrepancies between physician orders for Lisinopril and what was administered to the resident.The need to carry out physician orders as prescribed was discussed with Staff 1 (Executive Director) and Staff 2 on 01/10/23. They acknowledged the findings, and both reported they had begun to make changes to the medication administration system.
Plan of Correction:
Plan of correction for tab C 3031. Resident 1,4 and 5's eMAR's were reviewed for accuracy, current physician orders were obtained for all medications, clarification or discontinuation of orders were obtained and all medications are on site. Facility inplement new ordering system for timely delivery of medications. 2. Missed medication report will be reviewed each shift by med staff and supply availablility reviewed twice a week. Routine audit of MARS for holes and exceptions.3. Weekly and quarterly.4. WD and RSD